Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.120
+0.170 (5.76%)
Jun 23, 2025, 4:00 PM - Market closed
Cytek Biosciences Analyst Ratings
Total Analysts
4
Consensus Rating
Hold
Price Target
$6.00
Upside
+92.31%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +124.36% | May 28, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $3.5 → $3 | Strong Sell | Maintains | $3.5 → $3 | -3.85% | May 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +92.31% | Mar 19, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +156.41% | Mar 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $8.5 | Buy | Maintains | $8 → $8.5 | +172.44% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $8.5 → $8 | Buy | Maintains | $8.5 → $8 | +156.41% | Aug 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $10 → $8.5 | Buy | Maintains | $10 → $8.5 | +172.44% | May 13, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +220.51% | Mar 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +220.51% | Feb 29, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $9 | Buy | Initiates | $9 | +188.46% | Dec 14, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +124.36% | Nov 9, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $13 → $8 | Hold | Maintains | $13 → $8 | +156.41% | Oct 24, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $10 | Buy | Maintains | $15 → $10 | +220.51% | Oct 16, 2023 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Jul 19, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +316.67% | May 11, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +284.62% | May 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.